Chemed executive exercises 2,599 stock options
Chemed Corp executive Joel L. Wherley, CEO of Vitas Healthcare, exercised stock options for 2599.0000 shares of capital stock at $445.3500 per share on 2026-08-05.
Rhea-AI Filing Summary
Chemed Corp executive Joel L. Wherley, CEO of Vitas Healthcare, exercised stock options for 2599.0000 shares of capital stock at $445.3500 per share on 2026-08-05. The options, vesting in three equal annual installments commencing 10/28/2022, were fully exercised, leaving him with 30220.0000 direct shares. In a related transaction, 2270.0000 shares of capital stock at $542.6200 per share were withheld to cover the purchase price and tax obligation on the option exercise.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy with tandem tax withholding) F2 | 2,599 | $445.35 | $1.16M |
| Exercise | Capital Stock | 2,599 | $445.35 | $1.16M |
| Tax Withholding | Capital Stock F1 | 2,270 | $542.62 | $1.23M |
Footnotes (2)
- F1. Payment of purchase price and tax obligation on stock option exercise.
- F2. Vesting in three equal annual installments commencing 10/28/2022.
Key Figures
Key Terms
Stock Option (right to buy with tandem tax withholding) financial
tax-withholding disposition financial
Capital Stock financial
derivative security financial
Payment of purchase price and tax obligation financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did CHE (Chemed Corp) disclose about Joel L. Wherley’s recent equity transactions?
What type of derivative security did Joel L. Wherley exercise at CHE?
How were taxes and purchase price handled for Joel L. Wherley’s CHE option exercise?
What does the vesting schedule look like for the CHE options exercised by Joel L. Wherley?
AI-generated analysis. How Rhea-AI works. Not financial advice.